Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $194.2600 (1.07%) ($191.0800 - $195.9000) on Tue. Jun. 26, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.22% (three month average) | RSI | 46 | Latest Price | $194.2600(1.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 0.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.11% in a week (0% probabilities). VXX(-16%) TLT(-16%) VIXM(-13%) UUP(-8%) GDXJ(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.11% (StdDev 2.22%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $194.83 | 5 Day Moving Average | $196.73(-1.26%) | 10 Day Moving Average | $194.34(-0.04%) | 20 Day Moving Average | $194.83(-0.29%) | To recent high | -2.7% | To recent low | 28.8% | Market Cap | $3.122b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |